Ontology highlight
ABSTRACT: Background/objective
Moxifloxacin is a fluoroquinolone that is commonly used in adults, but not children. Certain clinical situations compel pediatric clinicians to use moxifloxacin, despite its potential for toxicity and limited pharmacokinetics (PK) data. Our objective was to further characterize the pharmacokinetics of moxifloxacin in children.Methods
We performed an opportunistic, open-label population PK study of moxifloxacin in children < 18 years of age who received moxifloxacin as part of standard care. A set of structural PK models and residual error models were explored using nonlinear mixed-effects modeling. Covariates with known biological relationships were investigated for their influence on PK parameters.Results
We obtained 43 moxifloxacin concentrati
SUBMITTER: Greenberg RG
PROVIDER: S-EPMC9768852 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature